Total Payments
$41,859
2024 Payments
$3,804
Companies
82
Transactions
1,217
Medicare Patients
2,051
Medicare Billing
$290,168
Payment Breakdown by Category
Food & Beverage$41,505 (99.2%)
Education$289.26 (0.7%)
Other$65.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $41,505 | 1,210 | 99.2% |
| Education | $289.26 | 4 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $65.00 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $22,726 | 72 | $0 (2020) |
| ABBVIE INC. | $2,577 | 166 | $0 (2024) |
| Biogen, Inc. | $1,529 | 86 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,226 | 91 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,103 | 63 | $0 (2023) |
| UCB, Inc. | $914.73 | 40 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $876.00 | 51 | $0 (2024) |
| Allergan, Inc. | $754.40 | 69 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $714.20 | 81 | $0 (2023) |
| Genentech USA, Inc. | $499.79 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,804 | 190 | ABBVIE INC. ($732.94) |
| 2023 | $2,869 | 158 | AbbVie Inc. ($544.66) |
| 2022 | $2,725 | 149 | ABBVIE INC. ($558.16) |
| 2021 | $2,670 | 169 | AbbVie Inc. ($459.32) |
| 2020 | $1,307 | 89 | Teva Pharmaceuticals USA, Inc. ($270.29) |
| 2019 | $1,884 | 123 | Teva Pharmaceuticals USA, Inc. ($244.13) |
| 2018 | $24,395 | 164 | Sunovion Pharmaceuticals Inc. ($22,447) |
| 2017 | $2,205 | 175 | Allergan Inc. ($174.79) |
All Payment Transactions
1,217 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Azurity Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.53 | General |
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Neurology | ||||||
| 12/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Neurology | ||||||
| 12/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $0.81 | General |
| Category: Neurology | ||||||
| 11/27/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Neurology | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/22/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: PAIN | ||||||
| 11/08/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Neuroscience | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Immunology | ||||||
| 10/22/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Neurology | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 529 | 657 | $149,247 | $76,231 |
| 2022 | 8 | 413 | 541 | $112,685 | $59,241 |
| 2021 | 8 | 557 | 724 | $154,736 | $83,487 |
| 2020 | 8 | 552 | 713 | $145,259 | $71,209 |
Total Patients
2,051
Total Services
2,635
Medicare Billing
$290,168
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 102 | 102 | $35,700 | $16,045 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 156 | $25,509 | $13,499 | 52.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 44 | 45 | $24,750 | $13,231 | 53.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 99 | $21,681 | $11,930 | 55.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 55 | 106 | $15,191 | $7,887 | 51.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 102 | $11,383 | $6,705 | 58.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 27 | 27 | $7,953 | $3,661 | 46.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 20 | 20 | $7,080 | $3,273 | 46.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 168 | $27,471 | $14,423 | 52.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 61 | 78 | $17,082 | $10,169 | 59.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 54 | 54 | $18,900 | $8,874 | 47.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 25 | 26 | $14,300 | $7,476 | 52.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 46 | 84 | $12,038 | $6,488 | 53.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 90 | $10,044 | $5,656 | 56.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 27 | 28 | $8,247 | $4,058 | 49.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 13 | 13 | $4,602 | $2,097 | 45.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 126 | 175 | $28,616 | $16,426 | 57.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 86 | 86 | $30,100 | $14,226 | 47.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 74 | 97 | $21,243 | $12,346 | 58.1% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 40 | 40 | $22,000 | $11,751 | 53.4% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 75 | 136 | $19,490 | $11,073 | 56.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 131 | $14,720 | $8,142 | 55.3% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 39 | 39 | $11,487 | $5,920 | 51.5% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 20 | 20 | $7,080 | $3,603 | 50.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 95 | 95 | $31,702 | $15,029 | 47.4% |
About Dr. Krishnababu Chunduri, MD
Dr. Krishnababu Chunduri, MD is a Neurology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1154316537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Krishnababu Chunduri, MD has received a total of $41,859 in payments from pharmaceutical and medical device companies, with $3,804 received in 2024. These payments were reported across 1,217 transactions from 82 companies. The most common payment nature is "Food and Beverage" ($41,505).
As a Medicare-enrolled provider, Chunduri has provided services to 2,051 Medicare beneficiaries, totaling 2,635 services with total Medicare billing of $290,168. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Fort Worth, TX
- Active Since 09/13/2005
- Last Updated 10/10/2011
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154316537
Products in Payments
- APTIOM (Drug) $22,690
- BOTOX (Biological) $982.35
- KESIMPTA (Drug) $877.35
- NUPLAZID (Drug) $829.08
- UBRELVY (Drug) $742.50
- QULIPTA (Drug) $707.33
- TYSABRI (Biological) $651.30
- OXTELLAR XR (Drug) $572.77
- Briviact (Drug) $496.01
- INGREZZA (Drug) $403.12
- Aimovig (Biological) $332.75
- Xeomin (Biological) $325.70
- ULTOMIRIS (Biological) $322.09
- DUOPA (Drug) $316.09
- AJOVY (Biological) $315.14
- Leqembi (Drug) $302.58
- RYTARY (Drug) $293.35
- VYVGART (Drug) $244.22
- NURTEC ODT (Drug) $230.18
- OCREVUS (Biological) $225.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fort Worth
Dr. Hamid Kadiwala, M.d, M.D
Neurology — Payments: $139,323
Neurology $139,323
Horacio Chiong-Rivero, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $83,086
Neurology $83,086
Sharique Ansari, M.d., Mph, M.D., MPH
Neurology — Payments: $79,831
Neurology $79,831
Leila Bostan Shirin, M.d, M.D
Neurology — Payments: $35,690
Neurology $35,690
Jiangping Liu, Md, MD
Neurology — Payments: $33,262
Neurology $33,262
Dr. Mary Quiceno, M.d, M.D
Neurology — Payments: $28,815
Neurology $28,815